Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Emi, Terasawa"'
Autor:
Rajesh Pahwa, Jason Aldred, Aristide Merola, Niodita Gupta, Emi Terasawa, Viviana Garcia-Horton, David R. Steffen, Prasanna L. Kandukuri, Yanjun Bao, Omar Ladhani, Connie H. Yan, Vivek Chaudhari, Stuart H. Isaacson
Publikováno v:
Clinical Parkinsonism & Related Disorders, Vol 8, Iss , Pp 100181- (2023)
Introduction: Carbidopa/levodopa enteral suspension (CLES) previously demonstrated reduction in total daily OFF from baseline by over 4 hours in advanced Parkinson’s disease patients across 54 weeks. Evidence on CLES’s long-term effectiveness on
Externí odkaz:
https://doaj.org/article/ed5b36cf53c5474baa6f55f091839295
Autor:
Lieneke F.M. Ariëns, Abhijit Gadkari, Harmieke van Os-Medendorp, Rajeev Ayyagari, Emi Terasawa, Andreas Kuznik, Zhen Chen, Gaëlle Bégo-Le Bagousse, Yufang Lu, Elena Rizova, Neil M.H. Graham, Gianluca Pirozzi, Marjolein De Bruin-Weller, Laurent Eckert
Publikováno v:
Acta Dermato-Venereologica, Vol 99, Iss 10, Pp 851-857 (2019)
Dupilumab is approved for uncontrolled moderate-to-severe atopic dermatitis (AD); cyclosporine is approved for severe AD for
Externí odkaz:
https://doaj.org/article/cb9d787cf6bd4596bf1c42e03864f80f
Autor:
Neal Shore, Viviana Garcia-Horton, Emi Terasawa, Rajeev Ayyagari, Jamie Partridge Grossman, Adrianus Reginald Waldeck
Publikováno v:
Future Oncology. 19:385-395
Approval of apalutamide, enzalutamide and darolutamide has transformed the treatment landscape and guideline recommendations for patients with nonmetastatic castration-resistant prostate cancer but now raises the issue of decision-making regarding tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b13c75449c8448b3df9d694aa040410
https://doi.org/10.2217/fon-2022-1123
https://doi.org/10.2217/fon-2022-1123
Autor:
Neal, Shore, Shan, Jiang, Viviana, Garcia-Horton, Emi, Terasawa, David, Steffen, Andi, Chin, Rajeev, Ayyagari, Jamie, Partridge, A Reginald, Waldeck
Publikováno v:
Advances in Therapy. 39:5025-5042
Three novel androgen receptor inhibitors are approved in the USA for the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC): apalutamide, enzalutamide, and darolutamide. All three therapies have demonstrated prolonged metastasi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52d39ee61cc00e5bad4b07988c648c6a
https://doi.org/10.1007/s12325-022-02245-8
https://doi.org/10.1007/s12325-022-02245-8
Autor:
Rajesh Pahwa, Jason Aldred, Niodita Gupta, Emi Terasawa, Viviana Garcia-Horton, David R. Steffen, Prasanna L. Kandukuri, Vivek S. Chaudhari, Yash J. Jalundhwala, Yanjun Bao, Pavnit Kukreja, Stuart H. Isaacson
Publikováno v:
Neurology and Therapy. 11:711-723
A clinical trial in advanced Parkinson's disease (APD) has established the superiority of carbidopa/levodopa enteral suspension (CLES) in reducing total patient "off" time (OFF) and increasing total "on" time without troublesome dyskinesia (ON-woTD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a348567fe8616407ac790670e5c49c0
https://doi.org/10.1007/s40120-022-00332-0
https://doi.org/10.1007/s40120-022-00332-0
Autor:
Steven Deitelzweig, Emi Terasawa, Amiee Kang, Nipun Atreja, Dionne M. Hines, Ahmed Noman, Xuemei Luo
Publikováno v:
Current medical research and opinion. 38(11)
In recent years, US payers have increased usage of formulary exclusions as a means to help manage costs. Earlier this year, one of the largest pharmacy benefit managers in the country added Eliquis (apixaban), the most widely used anticoagulant, to i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d667e0c74d58cb071e45b6d7e2bf8e0
https://pubmed.ncbi.nlm.nih.gov/36164763
https://pubmed.ncbi.nlm.nih.gov/36164763
Autor:
Zhen Chen, Laurent Eckert, Lieneke F.M. Ariëns, Neil M.H. Graham, Rajeev Ayyagari, Emi Terasawa, Gianluca Pirozzi, Abhijit Gadkari, Marjolein S. de Bruin-Weller, Harmieke van Os-Medendorp, Andreas Kuznik, Gaëlle Bégo-Le Bagousse, E. Rizova, Yufang Lu
Publikováno v:
Acta Dermato-Venereologica, Vol 99, Iss 10, Pp 851-857 (2019)
Dupilumab is approved for uncontrolled moderate-to-severe atopic dermatitis (AD); cyclosporine is approved for severe AD for ≤ 1 year. The efficacy/effectiveness of these treat-ments was compared indirectly. Regression models used pooled patient-le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ca3f36e53c736587b5b7294fc40dbd1
https://doi.org/10.2340/00015555-3219
https://doi.org/10.2340/00015555-3219
Autor:
A. Reginald Waldeck, Viviana Garcia-Horton, Neal D. Shore, Emi Terasawa, Susan Halabi, Rajeev Ayyagari, Shan Jiang
Publikováno v:
The Journal of urology. 206(2)
No published head-to-head randomized trials have compared the safety and efficacy of darolutamide vs apalutamide or enzalutamide in nonmetastatic castration-resistant prostate cancer. This study compares prespecified adverse events and metastasis-fre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b9569e108d516bcd88adc04463ef186
https://pubmed.ncbi.nlm.nih.gov/33818140
https://pubmed.ncbi.nlm.nih.gov/33818140
Autor:
Brooks D. Cash, Mei Lu, Emi Terasawa, Brian Terreri, Shawn Du, Rajeev Ayyagari, Paul Feuerstadt, Anthony Lembo, Baha Moshiree, Linda Nguyen, Mena Boules, Philip Schoenfeld
Publikováno v:
American Journal of Gastroenterology. 116:S239-S240
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34f2cb2745ab678b58752dabafc37060
https://doi.org/10.14309/01.ajg.0000774588.56152.30
https://doi.org/10.14309/01.ajg.0000774588.56152.30
Autor:
Rajeev Ayyagari, Mei Lu, Brian Terreri, Linda Nguyen, Brooks D. Cash, Mena Boules, Emi Terasawa, Shawn Du, Anthony Lembo, Baha Moshiree, Paul Feuerstadt
Publikováno v:
American Journal of Gastroenterology. 116:S224-S225
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22d9c1acc09a88b8826fa13103334de4
https://doi.org/10.14309/01.ajg.0000774480.91105.7d
https://doi.org/10.14309/01.ajg.0000774480.91105.7d